Literature DB >> 12193045

Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin.

Tobias Traupe1, Livius V D'Uscio, Klaus Muenter, Henning Morawietz, Wilhelm Vetter, Matthias Barton.   

Abstract

This study investigated vascular reactivity in response to acetylcholine, in the presence of acute inhibition of nitric oxide synthase, in the carotid artery and aorta of obese C57Bl6/J mice fed on a high-fat diet for 30 weeks, and of control mice. A subgroup of obese animals was also treated with the ET(A) receptor antagonist darusentan (50 mg x kg(-1) x day(-1)). In vascular rings from control animals, acetylcholine caused endothelium-dependent contractions in the carotid artery, but not in the aorta. In vascular rings from obese mice, contractility to acetylcholine was also evident in the aorta, and that in the carotid artery was increased compared with control mice. ET(A) receptor blockade by darusentan treatment of the obese mice prevented enhanced vasoconstriction to acetylcholine, resulting in mild vasodilatation. Thus obesity increases endothelium-dependent vasoconstriction in the absence of endothelial nitric oxide. This effect can be completely prevented by chronic ET(A) receptor blockade, suggesting that endothelin modulates increased endothelium-dependent vasoconstriction in obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193045     DOI: 10.1042/CS103S013S

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

Review 1.  Childhood obesity: a life-long health risk.

Authors:  Matthias Barton
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

Review 2.  Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction.

Authors:  Matthias Barton; Oliver Baretella; Matthias R Meyer
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice.

Authors:  Juha Ketonen; Taru Pilvi; Eero Mervaala
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

Review 4.  Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis.

Authors:  Matthias Barton
Journal:  Pflugers Arch       Date:  2010-07-16       Impact factor: 3.657

5.  Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.

Authors:  Pierluigi Carratù; Valentina Anna Ventura; Mauro Maniscalco; Silvano Dragonieri; Simona Berardi; Roberto Ria; Vitaliano Nicola Quaranta; Angelo Vacca; Fiorella Devito; Marco Matteo Ciccone; Barbara Anne Phillips; Onofrio Resta
Journal:  Sleep Breath       Date:  2015-09-18       Impact factor: 2.816

6.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

7.  Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors.

Authors:  A Sánchez; P Martínez; M Muñoz; S Benedito; A García-Sacristán; M Hernández; D Prieto
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 8.  Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.

Authors:  Jamison Wyatt; Shailesh Nandish; Rene Oliveros; Adrienne S Zion; Michael S Lujan; Robert Chilton
Journal:  Vasc Health Risk Manag       Date:  2010-02-04

Review 9.  Fat intake and cardiovascular response.

Authors:  Marlen Damjanovic; Matthias Barton
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

10.  G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  J Endocrinol       Date:  2015-08-24       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.